Shenzhen Hepalink Pharmaceutical Group Co., Ltd. (HKG:9989)

HKG:9989 Statistics

Total Valuation

HKG:9989 has a market cap or net worth of HKD 17.51 billion. The enterprise value is 17.60 billion.

Market Cap	17.51B
Enterprise Value	17.60B

Important Dates

The next estimated earnings date is Wednesday, October 29, 2025.

Earnings Date	Oct 29, 2025
Ex-Dividend Date	May 26, 2025

Share Statistics

Current Share Class	220.09M
Shares Outstanding	n/a
Shares Change (YoY)	-0.56%
Shares Change (QoQ)	-0.04%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	422.05M

Valuation Ratios

The trailing PE ratio is 39.47.

PE Ratio	39.47
Forward PE	n/a
PS Ratio	3.05
PB Ratio	1.31
P/TBV Ratio	1.69
P/FCF Ratio	9.11
P/OCF Ratio	8.20
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 23.02, with an EV/FCF ratio of 9.16.

EV / Earnings	39.68
EV / Sales	3.07
EV / EBITDA	23.02
EV / EBIT	42.68
EV / FCF	9.16

Financial Position

The company has a current ratio of 2.29, with a Debt / Equity ratio of 0.25.

Current Ratio	2.29
Quick Ratio	1.14
Debt / Equity	0.25
Debt / EBITDA	3.68
Debt / FCF	1.76
Interest Coverage	1.28

Financial Efficiency

Return on equity (ROE) is 3.14% and return on invested capital (ROIC) is 2.02%.

Return on Equity (ROE)	3.14%
Return on Assets (ROA)	1.81%
Return on Invested Capital (ROIC)	2.02%
Return on Capital Employed (ROCE)	3.97%
Revenue Per Employee	2.98M
Profits Per Employee	230,369
Employee Count	1,926
Asset Turnover	0.29
Inventory Turnover	0.69

Taxes

In the past 12 months, HKG:9989 has paid 64.61 million in taxes.

Income Tax	64.61M
Effective Tax Rate	13.33%

Stock Price Statistics

The stock price has increased by +47.06% in the last 52 weeks. The beta is 0.41, so HKG:9989's price volatility has been lower than the market average.

Beta (5Y)	0.41
52-Week Price Change	+47.06%
50-Day Moving Average	6.15
200-Day Moving Average	4.97
Relative Strength Index (RSI)	37.50
Average Volume (20 Days)	1,466,875

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, HKG:9989 had revenue of HKD 5.74 billion and earned 443.69 million in profits. Earnings per share was 0.30.

Revenue	5.74B
Gross Profit	1.72B
Operating Income	568.94M
Pretax Income	484.58M
Net Income	443.69M
EBITDA	879.40M
EBIT	568.94M
Earnings Per Share (EPS)	0.30

Balance Sheet

The company has 3.36 billion in cash and 3.39 billion in debt, giving a net cash position of -34.36 million.

Cash & Cash Equivalents	3.36B
Total Debt	3.39B
Net Cash	-34.36M
Net Cash Per Share	n/a
Equity (Book Value)	13.38B
Book Value Per Share	9.08
Working Capital	5.87B

Cash Flow

In the last 12 months, operating cash flow was 2.13 billion and capital expenditures -211.74 million, giving a free cash flow of 1.92 billion.

Operating Cash Flow	2.13B
Capital Expenditures	-211.74M
Free Cash Flow	1.92B
FCF Per Share	n/a

Margins

Gross margin is 29.90%, with operating and profit margins of 9.91% and 7.73%.

Gross Margin	29.90%
Operating Margin	9.91%
Pretax Margin	8.44%
Profit Margin	7.73%
EBITDA Margin	15.32%
EBIT Margin	9.91%
FCF Margin	33.50%

Dividends & Yields

This stock pays an annual dividend of 0.27, which amounts to a dividend yield of 5.12%.

Dividend Per Share	0.27
Dividend Yield	5.12%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	n/a
Buyback Yield	0.56%
Shareholder Yield	5.68%
Earnings Yield	2.53%
FCF Yield	10.98%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

HKG:9989 has an Altman Z-Score of 2.85 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.85
Piotroski F-Score	7